Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Nick Opich and Anne Donohoe are back for a new episode with special guest Sherry Rais, Co-Founder and CEO of Enthea, a mental health company dedicated to providing access to safe and affordable psychedelic-assisted therapy. Sherry joins us this week to discuss ketamine accessibility and how Enthea is making it more affordable; myths about ketamine that need to be dispelled; and Enthea’s 2024 plans to address underserved communities.

If you are interested in learning more about Sherry and Enthea, visit the links in our show notes. Also, be sure to follow Sherry and Enthea on LinkedIn and Instagram.

So, sit back and enjoy our conversation with Sherry Rais of Enthea.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Nick Opich & Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true